Morning Light

What it is

Bright light therapy usually means sitting in front of a light box that gives bright white light, often in the morning. Trials used visors or boxes from 2,500 lux [1] to about 10,000 lux at the eye [2]. Daylight is the natural version: people who spend more time outdoors in daylight are studied in separate observational research [3].

How it might work

Proposed mechanism: light reaches the eyes and sets the body clock in the brain, which controls the timing of sleep and alertness. Bright light taken in the morning is thought to move the clock earlier, and evening light later [4]. In a controlled study of healthy young adults, bright light alone shifted the body clock about as much as melatonin alone [5]. One trial in Parkinson disease found that salivary cortisol fell in the bright-light group but rose in the control group [6].

What the research says

The strongest positive evidence is for depression. A 2025 meta-analysis of 11 randomised trials (858 people) found that adding bright light to usual treatment raised remission to 40.7% from 23.5% with control, and response to 60.4% from 38.6% [7]. A 2024 meta-analysis of 15 trials (883 people) found a moderate benefit on depression scores [8]. Older adults with non-seasonal depression also improved in six trials (359 people) [9].

Not every trial agreed. In a trial of 224 hospitalised teenagers with depression, morning light did not beat placebo red light, although both groups improved [2]. In 43 adults on antidepressants, depressive symptoms did not fall significantly after four weeks of morning light [10]. A 2020 meta-analysis of 23 trials (1,120 people) found a mild to moderate benefit but rated the evidence as low quality [11].

For seasonal affective disorder (winter depression), a 2020 meta-analysis of 19 trials found bright light beat placebo for depression scores (standardised mean difference -0.37), and the chance of response was 42% higher (risk ratio 1.42) [12]. A 2025 network analysis of 17 trials (773 people) ranked white light as the most effective visible light for seasonal depression [13].

In bipolar depression, a 2020 meta-analysis of seven trials (259 people) found a moderate benefit on depression scores, and response was more likely with light (odds ratio 2.32) [14]. A 46-person trial with midday light reported remission of 68.2% against 22.2% with placebo [15]. A trial of 74 randomised people given one hour of morning light for two weeks reported response of 78.19% against 43.33% [16]. A 2012 trial of 44 people found no significant difference from negative ion placebo [17].

For sleep, a 2024 meta-analysis of 10 trials in insomnia found light therapy improved self-rated sleep quality (Pittsburgh score down 2.89 points) and insomnia severity (down 2.16 points) [18]. A 2026 meta-analysis of 14 studies (444 people with insomnia) used blue-enriched light and found better self-rated sleep quality and less daytime sleepiness, but no change in total sleep time [19]. A 2023 review of 22 trials (685 people) found, in a meta-analysis of 13 of them, less time awake after falling asleep, but no clear change in how long it took to fall asleep or in total sleep time [4]. In 12 studies with 679 people with cancer, light therapy improved sleep quality, but not insomnia severity [20]. In a 2026 randomised trial of 208 women having chemotherapy, bright light glasses did not improve insomnia or fatigue beyond groups without light, although an exploratory subgroup with metastatic cancer improved [21].

For the body clock, a 2019 meta-analysis of 40 studies found that light interventions advanced delayed sleep timing and improved sleep continuity [22]. In teenagers with a late body clock, cognitive-behaviour therapy plus morning light outperformed a waitlist: 13% still met the diagnosis after treatment, against 82% on the waitlist [23].

Outside the lab, people who spend more time in daylight tend to report better mood and sleep. In a UK study of over 400,000 adults, each extra hour outdoors was linked to lower odds of lifetime major depression (odds ratio 0.92 to 0.98) and fewer insomnia symptoms (odds ratio 0.94 to 0.97) [3]. In 932 children, more weekday daylight was linked to fewer depressive symptoms 19 months later [24]. In a cohort of 70,827 adults, time outdoors was not linked to depression overall, though late chronotypes had lower odds with more daylight [25].

In a cohort of 362,094 adults, time outdoors had a J-shaped link with dementia: risk was lowest at about 1.5 hours a day on average, and low exposure was linked to higher risk [26].

In 92 female nurses on evening or night shifts with insomnia, bright light during the first half of the shift, plus dark glasses after work, improved insomnia scores more than control [27]. A 2022 review of five studies found that evening light shifted the body clock later and improved sleep quality, and its authors called the benefits tentative [28].

Doses used in studies

These are doses from trials, not recommendations.

Morning light for 15, 30 or 60 minutes daily for four weeks, in adults with traumatic stress [29]. Bright white light at 10,000 lux for 60 minutes each morning for four weeks, in an open-label study of veterans with brain injury [30]. One hour every morning for two weeks in bipolar depression [16]. 7,000 lux at midday for six weeks in bipolar depression [15]. Up to 20 sessions at 10,000 lux over four weeks in hospitalised teenagers [2].

For insomnia, greater sleep-quality benefit was seen with intensities above 5,000 lux, at least four weeks, and a light box [20]. A circadian study used about 3,000 lux for three hours, starting an hour before usual wake time [5]. Across depression trials, effects were larger in trials of two weeks or less, or with 60 minutes or more of daily exposure [8]. Placebo conditions used dim red light at 50 lux [15] or 100 lux [2].

Safety and interactions

Eye discomfort or vision complaints were reported by 0% to 45% of participants across light therapy studies, with no clear link to dose [31]. Light therapy trials describe the treatment as well tolerated [14], and the bipolar meta-analysis with a control group reported no serious adverse effects [32]. Headache rates were not reported in the abstracts reviewed for this page, so common side effects are not well quantified.

A systematic review found no evidence of eye damage from light therapy in physically healthy, unmedicated people. The eye-safety data are for light-therapy devices such as light boxes, not for looking at the sun [31]. It did find one case of maculopathy in a person taking the photosensitising antidepressant clomipramine, and it said the eye safety of people with existing eye abnormalities or raised light sensitivity needs more study [31]. People with an eye condition, or who take medicines that raise light sensitivity, should ask a doctor or eye specialist first.

Bipolar disorder: in the pooled trials, light therapy did not clearly increase mood switches, but switches were rare and the confidence interval was wide (odds ratio 1.30, 95% CI 0.38 to 4.44), so an increase cannot be ruled out [14]. Manic switches were 1.1% with light and 1.2% with control in four trials [32]. People with bipolar disorder should ask a doctor before starting, and should tell their clinician about any change in mood.

Pregnancy and breastfeeding: in eight trials in pregnant or postpartum women, light therapy had no serious adverse effects, but the trials were small [33]. No studies on breastfeeding were found in this search.

Upper limits: no upper limit for light-box use is set in the studies reviewed here, and the eye-safety review found no eye damage in physically healthy, unmedicated people [31]. No trials in people with kidney, liver or bleeding disorders were found in this search.

Medicine interactions: combined melatonin and bright light has been tested in healthy people and in older people with cognitive decline; the authors say the reported adverse effects of melatonin in older people must be considered [34]. Photosensitising medicines are covered above [31].

This page does not cover UV exposure from the sun, which is a separate topic.

Caveats and open questions

Trials are small and varied in light dose, timing and design, so comparisons are difficult [12]. A review of nine blue-enriched light trials found no efficacy compared with inactive or active light for seasonal or non-seasonal depression [35]. Several authors of the bipolar and blue-light reviews reported industry payments, including speaker fees, consulting and research grants [14][35].

For morning timing specifically, the evidence is thinner. In a 2023 review, the finding that morning light advanced sleep-wake rhythms was qualitative [4]. In a correlational study of 877 older men, afternoon light, not morning or evening light, best separated people with more and less fragmented sleep, and the authors suggest afternoon light therapy might be more effective [36]. In 60 adolescents and young adults with delayed sleep-wake phase disorder, green or red light and morning or sedentary activity made no significant difference to outcomes, all groups improved, and 38% asked for further treatment beyond the three weeks [37].

Some trials had no placebo group. In a 46-person trial of morning light in traumatic stress, symptoms fell in all dose groups and no placebo group was included [29]. A 2023 meta-analysis of young people with depression concluded that brighter light has not yet been shown to beat dimmer light [38].

In an 11-trial Cochrane review, light therapy had no effect on sleep, cognition or behaviour in dementia [39]. In hospitalised adults, the effect of bright light on delirium was uncertain (risk ratio 0.64, 95% CI 0.38 to 1.07), with very low certainty [40].

Evidence on light for preventing seasonal depression comes from one small, high-risk-of-bias trial of 46 people [1]. Observational studies on daylight cannot show cause and effect [3], and one prospective cohort of 70,827 adults found no overall link to depression [25].